Complement component C9
| GO Term |
|---|
| extracellular region |
| extracellular space |
| plasma membrane |
| extracellular exosome |
| blood microparticle |
| membrane attack complex |
| other organism cell membrane |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 24 |
|
|||
| 26 |
|
|||
| 32 |
|
|||
| 48 | C-linked (Man) tryptophan |
|
||
| 51 | C-linked (Man) tryptophan; partial |
|
||
| 123 |
|
|
||
| 258 |
|
|||
| 277 | N-linked (GlcNAc...) asparagine | |||
| 415 | N-linked (GlcNAc...) (complex) asparagine |
|
||
| 518 |
|
|
| Pathway Name | Organism |
|---|---|
| Regulation of Complement cascade | Homo sapiens |
| Terminal pathway of complement | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060303 | complement component 9 deficiency | |
| DOID:0110027 | age related macular degeneration 15 | |
| DOID:2559 | opiate dependence |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025